Amylin Commands Weight Loss Attention as Industry Anticipates Novo's Phase III CagriSema Readout US$ 29.42 Min. order: 1 piece ★★★★★ 4.9 (140 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 26.93 Min. order: 1 piece ★★★★★ 4.7 (179 reviews) Sold : Login>>
Novo Nordisk's next-generation weight-loss drug CagriSema matches Lilly's Zepbound in major trial, but doesn't surpass it US$ 21.78 Min. order: 1 piece ★★★★★ 4.1 (66 reviews) Sold : Login>>
Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late-Stage Trial: Novo Nordisk Update US$ 29.15 Min. order: 1 piece ★★★★★ 5.0 (187 reviews) Sold : Login>>
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management US$ 22.61 Min. order: 1 piece ★★★★★ 4.7 (164 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 25.11 Min. order: 1 piece ★★★★★ 4.0 (158 reviews) Sold : Login>>